Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma.
about
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromesENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.Metastatic insulinoma in a patient with type 2 diabetes mellitus: case report and review of the literatureNANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreasThe use of targeted therapies in pancreatic neuroendocrine tumours: patient assessment, treatment administration, and management of adverse events.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesPancreatic neuroendocrine tumors: biology, diagnosis,and treatmentNew therapeutic options for metastatic malignant insulinomas.Management of malignant insulinoma.Targeted therapy with kinase inhibitors in aggressive endocrine tumors.Adult-onset hyperinsulinaemic hypoglycaemia in clinical practice: diagnosis, aetiology and management.The treatment of hyperinsulinemic hypoglycaemia in adults: an update.Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.Prolonged life-threatening hypoglycaemia following dose escalation of octreotide LAR in a patient with malignant polysecreting pancreatic neuroendocrine tumour.[High grade insulinoma detected in a patient with a 5-year history of severe hypoglycemias].Everolimus Directly Suppresses Insulin Secretion Independently of Cell Growth Inhibition.
P2860
Q24603675-7D13D95B-7D5D-4BCB-A335-FA45F6FD44A6Q34248487-018C93C1-FA82-4A06-B4A8-8AC1E2A29ECCQ34572156-AB402247-8CCE-4ABA-827F-8E641D61CFFBQ35001777-081F1F8F-A304-4703-BF35-F499FC6C617AQ37117596-E7716CA6-95E7-444B-9772-893D1D2A759FQ37125550-AAD23C3C-24B6-4961-995A-69043FB5484CQ37354131-969BFB29-0E0F-43E6-B4F4-CDBBFBB436A7Q37886036-3B5B57E2-E763-442F-80A4-006761E6EEA5Q38086515-F5D7B286-AA00-4678-BE50-6B365F0726B3Q38107011-0263D459-1F2C-44A9-AA7E-180463F71806Q38636269-1FD6E10E-FA19-4D4C-A856-FF9477AB9DEEQ38953515-27203584-DB4B-47F7-8E22-8DB1C97B3767Q38956091-319D1BDD-0A3A-447F-A9ED-1AEF501448B1Q42001885-4FA655EA-8063-4951-BDC1-48A2B023727EQ42124971-E83E4D66-4FCB-40A9-8F9F-36D1BE5C2DC1Q55297816-182EFFB0-E762-4B72-8E70-DDAC04580695
P2860
Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapies for the medical mana ...... operable malignant insulinoma.
@en
Therapies for the medical mana ...... operable malignant insulinoma.
@nl
type
label
Therapies for the medical mana ...... operable malignant insulinoma.
@en
Therapies for the medical mana ...... operable malignant insulinoma.
@nl
prefLabel
Therapies for the medical mana ...... operable malignant insulinoma.
@en
Therapies for the medical mana ...... operable malignant insulinoma.
@nl
P2093
P356
P1476
Therapies for the medical mana ...... noperable malignant insulinoma
@en
P2093
David E Henley
David Hurley
J Harvey Turner
Phillip G Claringbold
P304
P356
10.1530/EJE-09-1010
P577
2010-02-17T00:00:00Z